Status:

UNKNOWN

Predicting the Course of Chronic Obstructive Pulmonary Disease (COPD) in Primary Care

Lead Sponsor:

University of Zurich

Collaborating Sponsors:

Swiss National Science Foundation

Zurich Lung League

Conditions:

COPD

Eligibility:

All Genders

40+ years

Brief Summary

Background: COPD is a systemic illness; morbidity and mortality due to this disease are on the increase, and it has great impact on patients' lives. Most COPD patients are managed by general practitio...

Eligibility Criteria

Inclusion

  • Patients ≥40 years of age with COPD in GOLD stage II to IV (postbronchodilator FEV1/FVC≤0.70, postbronchodilator FEV1≤80% predicted) are eligible if in- or outpatient treatment of their last exacerbation ended ≥4 weeks ago.

Exclusion

  • Patients who received mechanical ventilation in the previous 12 months (because of extremely poor prognosis), patients with co-morbidities associated with a life expectancy of ≤12 months, patients diagnosed with dementia, psychosis or other psychiatric illness that invalidate assessment of patient-reported parameters and patients who cannot complete thr baseline assessment due to language difficulties.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2014

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT00706602

Start Date

May 1 2008

End Date

August 1 2014

Last Update

June 28 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute for primary care, University of Zurich

Zurich, Canton of Zurich, Switzerland, 8091